Nausea Clinical Trials

23 recruiting

Nausea Trials at a Glance

58 actively recruiting trials for nausea are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in Hangzhou, New York, and Halifax. Lead sponsors running nausea studies include Second Affiliated Hospital, School of Medicine, Zhejiang University, The Hospital for Sick Children, and Anhui Provincial Children's Hospital.

Browse nausea trials by phase

Treatments under study

About Nausea Clinical Trials

Looking for clinical trials for Nausea? There are currently 23 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Nausea trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Nausea clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 58 trials

Recruiting
Phase 3

Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting

VomitingNausea
Affiliated Hospital of Qinghai University222 enrolled1 locationNCT07208305
Recruiting
Phase 2

Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery

AnesthesiaSpinal FusionNausea and Vomiting, Postoperative
IWK Health Centre100 enrolled1 locationNCT06357234
Recruiting
Not Applicable

Dexmedetomidine and Propofol for Sedation in Cataract Surgery.

Nausea and VomitingDexmedetomidineSedation+7 more
Saint-Joseph University1,000 enrolled1 locationNCT07556133
Recruiting
Phase 2

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

NeoplasmsVomitingNausea+1 more
Eli Lilly and Company204 enrolled66 locationsNCT07169851
Recruiting
Phase 3

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

ObesityNausea and Vomiting
Vanda Pharmaceuticals280 enrolled10 locationsNCT07446439
Recruiting
Phase 2

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

Nausea and Vomiting Caused by Trastuzumab Deruxtecan
Second Affiliated Hospital, School of Medicine, Zhejiang University25 enrolled1 locationNCT07537673
Recruiting
Phase 2

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide

Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University25 enrolled1 locationNCT07537699
Recruiting
Phase 2

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel

Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University25 enrolled1 locationNCT07537660
Recruiting
Not Applicable

The Effect of Paedfusor TCI, Eleveld TCI, and Sevoflurane Anesthesia on Postoperative Awakening Agitation in Pediatric Patients

Emergence Delirium in Pediatric AnesthesiaPediatric AnesthesiaPostoperative Nausea and Vomiting (PONV)+1 more
Marmara University Pendik Training and Research Hospital150 enrolled2 locationsNCT07534956
Recruiting
Phase 3

Domperidone in Treating Patients With Gastrointestinal Disorders

Nausea and VomitingGastroparesisDyspepsia+4 more
M.D. Anderson Cancer Center200 enrolled1 locationNCT01696734
Recruiting
Not Applicable

Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)

VomitingNausea
Enterra Medical, Inc.148 enrolled20 locationsNCT06464926
Recruiting

Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8Early Stage Breast CarcinomaAnatomic Stage I Breast Cancer AJCC v8+1 more
Mayo Clinic70 enrolled5 locationsNCT05417867
Recruiting
Phase 2

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Nausea and Vomiting Chemotherapy-InducedNausea Post Chemotherapy
Helsinn Healthcare SA95 enrolled20 locationsNCT06904235
Recruiting

Quality Improvement Project to Reduce Preoperative Fasting Times Before Elective Procedures

Preoperative FastingPostoperative Nausea and Vomiting (PONV)Perioperative Patient Comfort / Quality of Care
University of Giessen1,000 enrolled1 locationNCT07488468
Recruiting
Not Applicable

Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting

NauseaPregnancy Emesis
University of Minnesota100 enrolled1 locationNCT07378839
Recruiting
Not Applicable

Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section

Postoperative IleusCesarean SectionPostoperative Nausea and Vomiting (PONV)+2 more
Nigde Omer Halisdemir University160 enrolled1 locationNCT07440667
Recruiting
Not Applicable

Vomiting Prevention in Children With Cancer

Quality of Life (QOL)Pediatric CancerChemotherapy Induced Nausea and Vomiting
The Hospital for Sick Children1,332 enrolled1 locationNCT06886451
Recruiting
Phase 3

Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients

PreventionNausea and Vomiting, Postoperative
Centre hospitalier de l'Université de Montréal (CHUM)260 enrolled1 locationNCT07248280
Recruiting

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Nausea and VomitingOlanzapineSolid Tumours
Shandong Cancer Hospital and Institute2,000 enrolled1 locationNCT07403370
Recruiting
Not Applicable

Brain-Stomach Circuits in Chronic Nausea

Chronic Nausea and Vomiting Syndrome
David Levinthal219 enrolled1 locationNCT07276035